AstraZeneca - Advancing computational pathology for biomarker discovery: From QCS to foundation models and multimodal analysis

Name: AstraZeneca - Advancing computational pathology for biomarker discovery: From QCS to foundation models and multimodal analysis
Start: 2026-11-16T12:15
End: 2026-11-16T12:35
Location: Messe Berlin

ESMO AI & Digital Oncology Congress 2026 · 16 November 2026 · 12:15–12:35 · The Stage

AstraZeneca - Advancing computational pathology for biomarker discovery: From QCS to foundation models and multimodal analysis was a session at ESMO AI & Digital Oncology Congress 2026 on 16 November 2026 in Berlin, with 1 speaker on record.

Speakers

Nicolas Brieu — Speaker Senior Director, Head of CP Computer Vision and AI, AstraZeneca